Showing results (41-50 of 160) with videos related to
Sort By:
Pageof 16
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 10, 2011
Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.BMC Nephrology|February 8, 2017
Effect of large weight reductions on measured and estimated kidney functionBernt Johan von Scholten, Frederik Persson, Maria S Svane, et al.Primary Care Diabetes|October 22, 2022
Biochemical profiling, pharmacological management and clinical outcomes in type 2 diabetes in Danish primary care from 2001 to 2015Niels Søndergaard Heinrich, Margit Kriegbaum, Mia Klinten Grand, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 21, 2012
Impact of glycaemic control on the effect of direct renin inhibition in the AVOID studyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.Kidney International|July 18, 2017
Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathyJulie Galsgaard, Frederik Persson, Tine Willum Hansen, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2011
Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.Journal of Diabetes and Its Complications|October 23, 2016
Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatmentEmilie Hein Zobel, Bernt Johan von Scholten, Morten Lindhardt, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 18, 2017
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal FunctionSergei Petrykiv, C David Sjöström, Peter J Greasley, et al.Diabetes Care|August 10, 2010
Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.Journal of Hypertension|June 8, 2013
Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?Frederik Persson, Xifeng Lu, Peter Rossing, et al.Pageof 16